Pay in 4 interest-free payments of $7.46 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
The EXSCEL trial (Bethel et al., 2020) and LEADER trial (Marso et al., 2016) investigated the effect of exenatide and liraglutide, respectively, on microvascular and cardiovascular outcomes in patients with type 2 diabetes
Combined these findings suggest the potential application of Ru(II)-OH as a catalyst for the transformation of GSH to GSSG
10.1105/tpc.009464 41 FoyerC
For research use only not for human consumption
Gastrointestinal events have appeared most frequently in trials (nausea, vomiting, diarrhea)
Presented for research literature review only Uematsu T et al
US$ 28.73
US$ 25.07
US$ 26.61
US$ 25.24
